Patient Characteristics, Treatment Patterns and Outcomes of Patients With Severe Asthma Treated With Tezepelumab in the Real World; a Retrospective, Observational Medical Chart Review Conducted in UK Severe Asthma Centres
Clinical trial NCT06455462 · COMPLETED
Trial details
- NCT number
- NCT06455462
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-04-22
- Primary completion
- 2025-11-25
- Enrollment
- 352
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.